Abstract
The fundamental characteristic of the adaptive immune system which has evolved in the vertebrates is the ability to recognise, and subsequently destroy, “foreign”, and potentially harmful, antigens. The selective advantage which the immune system confers is the capacity to resist infectious, and possibly malignant, disease. It has been apparent for many years that individuals in whom immune function is impaired, due either to a congenital defect or to other factors such as treatment with certain immunosuppressive drugs, exhibit an increased susceptibility to infection and, in some cases, an elevated risk of developing at least some forms of malignancy. There is an increasing awareness from rodent studies that a variety of drugs and environmental chemicals have the potential to unintentionally impair components of the immune system. Risk assessment, based upon data from chemically induced changes in one or more parameters of immune function, is, however, dependent upon a knowledge of the functional reserve of the immune system. One of the objectives of the meeting from which this report derives was to examine what sources of information are available, and what experimental protocols can be employed, to permit accurate evaluation of immunological reserve. Although, under normal circumstances, the immune system selectively and specifically recognises foreign antigen, it is clear that the potential to recognise “self” is present and that in certain circumstances this potential is realised. Antibodies directed against normal tissue antigens have been shown to be associated with, and in some instances the presumptive cause of, “autoimmune” disease. There is a growing list of drugs and chemicals which are capable of eliciting autoantibodies and pathological autoimmune reactions. A second purpose of this meeting and of this report was to review the current state of knowledge regarding drug- and chemical-induced autoimmunity.
Similar content being viewed by others
References
Aaronson DW (1980) Asthma: general concepts. In: Patterson RW (ed) Allergic diseases. JB Lippincott Company, Philadelphia, Toronto, pp 231–278
Adachi JD, Bensen WG, Singal DP, Powers PJ (1984) Gold-induced thrombocytopenia; platelet associated IgG and HLA typing in three patients. J Rheumatol 12: 355–357
Albini B, Glurich I, Andres A (1983) Mercuric chloride-induced immunologically mediated diseases in experimental animals. In: Porter GA (ed) Nephrotoxic mechanisms of drugs and environmental toxins. Plenum Medical Books Company, New York, pp 413–423
Allison AC, Denman AM, Barnes RD (1971) Hypothesis. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet ii: 135–140
Aten J, Bosman CB, Rozing J, Stijnen T, Hoedemaker PJ, Weening JJ (1988) Mercuric chloride-induced autoimmunity in the Brown Norway rat: cellular kinetics and major histocompatibility complex antigen expression. Am J Pathol 133: 127–138
Batchelor JR, Welsh KI, Mansilla Tinoco R, Dollery CT, Hughes GRV,Bernstein R, Ryan P, Naish PF, Aber GM, Bing RF, Russel GI (1980) Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet i: 1107–1109
Beaune PH, Dansette PM, Mansuy D, Kiffel L, Finck M, Amar C, Leroux JP, Homberg JC (1987) Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci USA 84: 551–555
Bekesi JG, Holland JF, Anderson HA, Fischbein AS, Rom W, Wolf MS, Selekoff IJ (1978) Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls. Science 199: 1207–1209
Bekesi JG, Roboz JP, Solomon S, Fischbein A, Roboz J, Selikoff IJ (1983) Persistent immune dysfunction in Michigan dairy farm residents exposed to polybrominated biphenyls. In: Hadden JW, Chedid L, Dukor P, Spreafico F, Willoughby D (eds) Advances in immunopharmacology 2. Pergamon Press, New York, pp 33–39
Black CM, Welsh KI, Walker AE, Bernstein RM, Catoggio LJ, McGregor AR, Lloyd Jones JK (1983) Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride. Lancet i: 53–55
Bruton OC (1952) Agammaglobulinaemia. Pediatrics 9: 722–727
Carlstedt-Duke JMB, Harnemo U-B, Hogberg B, Gustafsson JA (1981) Interaction of the hepatic receptor protein for 2,3,7,8-tetrachlorodibenzo-p-dioxin with DNA. Biochim Biophys Acta 672: 131–138
Chang KJ, Hsieh KH, Lee TP, Tang SY, Tung TC (1981) Immunologic evaluation of patients with PCB poisoning: determination of lymphocyte subpopulations. Toxicol Appl Pharmacol 61: 58–63
Chang KJ, Hsieh KH, Lee TP, Tung TC (1982a) Immunologic evaluation of patients with polychlorinated biphenyl poisoning: determination of phagocyte Fc and complement receptors. Environ Res 28: 329–334
Chang KJ, Hsieh KH, Tang SY, Tung TC, Lee TP (1982b) Immunologic evaluation of patients with polychlorinated biphenyl poisoning: evaluation of delayed-type skin hypersensitivity response and its relation to clinical status. J Toxicol Environ Health 9: 217–223
Chapel H, Haeney M (1984) Essentials of clinical immunology. Blackwell Scientific Publications, Oxford
Claas FHJ, van Rood JJ (1985) The interaction of drugs and endogenous substances with HLA class-I antigens. Prog Allergy 36: 135–150
Clark DA, Gauldie J, Szewczuk MR, Sweeney G (1981) Enhanced suppressor cell activity as a mechanism of immunosuppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (41275). Proc Soc Exp Biol Med 168: 290–299
Clark DA, Sweeney G, Safe S, Hancock E, Kilburn DG, Gauldie J (1983) Cellular and genetic basis for suppression of cytotoxic T-cell generation by haloaromatic hydrocarbons. Immunopharmacology 6: 143–153
Coblyn JS, Weinblatt M, Holdsworth D, Glass D (1981) Gold induced thrombocytopenia: a clinical and immunogenetic study of twenty-three patients. Ann Int Med 95: 178–181
Cohen I (1986) Regulation of autoimmune disease: physiological and therapeutic. Immunol Rev 94: 5–21
Dawkins RL, Christiansen FT, Zilko PJ (eds) (1982) In: Immunogenetics in rheumatology. Musculoskeletal diseases and d-penicillamine. Excerpta Medica, Amsterdam, pp 280–375
Dean JH, Luster MI, Boorman GA, Luebke RW, Lauer LD (1980) The effect of adult exposure to diethylstilbestrol in the mouse: alterations in tumor susceptibility and host resistance parameters. J Reticuloendothel Soc 28: 571–584
Dean JH, Thurmond LM, Lauer LD, House RV (1987) Comparative toxicology and correlative immunotoxicology in rodents. In: Burger EJ, Tardiff RG, Bellanti JA, (eds) Environmental chemical exposures and immune system integrity. Princeton Scientific Publishing Co., Princeton, pp 85–100
Descotes J (1988) Immunotoxicology of drugs and chemicals, 2nd edn. Elsevier, Amsterdam
DeSwarte RD (1980) Drug allergy. In: Patterson R (ed) Allergic diseases. JB Lippincott Company, Philadelphia, Toronto, pp 452–583
DeSwarte RD (1986) Drug allergy. An overview. Clin Rev Allergy 4: 143–169
De Weck AL (1983) Penicillins and cephalosporins. In: de Weck AL, Bundgaard JO (eds) Handbook of experimental pharmacology, Vol 63: Allergic reactions to drugs. Springer, Berlin, pp 423–482
DiGeorge AM (1968) Congenital absence of the thymus and its immunologic consequences. Concurrence with congenital hypoparathyroidism. In: Bergsma D, McKusick FA (eds) Immunologic deficiency diseases in man. Williams and Wilkins, Baltimore
Dighiero G, Lymberi J, Marie JC, Rouyse S, Butler-Browne GS, Whalen RG, Avrameas S (1983) Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol 135: 2267–2271
Donker AJ, Venuto RC, Vladutiu AO, Brentjens JR, Andres GA (1984) Effects of prolonged administration of d-penicillamine or captropril in various strains of rats. Brown Norway rats treated with d-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation. Clin Immunol Immunopathol 30: 142–155
Druet P, Sapin C, Druet E, Hirsch F (1983) Genetic control of mercury-induced immune response in the rat. In: Porter GA (ed) Nephrotoxic mechanisms of drugs and environmental toxins. Plenum Medical Book Company, New York, London, pp 425–435
Druet P, Hirsch F, Pelletier L, Druet E, Baran D, Sapin C (1987) Mechanisms of chemical-induced glomerulonephritis. In: Fowler BA (ed) Mechanisms of cell injury: implications for human health. Dahlem Konferenzen. John Wiley and Sons Ltd, Chichester, pp 153–173
Emery P, Panayi S, Huston G, Welsh KI, Mitchell SC, Shah RR, Idel JR, Smith RL, Waring RH (1984) d-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3. J Rheumatol 11: 626–632
Faith RE, Luster MI, Kimmel CA (1979) Effect of chronic developmental lead exposure on cell-mediated immune functions. Clin Exp Immunol 35: 413–420
Fillastre JP, Mery JP, Morel-Maroger L, Kanfer A, Godin M (1985) Drug-induced glomerulonephritis. In: Solez K, Whelton A (eds) Acute renal failure. Marcel Dekker, New York, Basel, pp 389–407
Fleuren GJ, DeHeer E, Burgers JV, Osnabrugge C, Hoedemaeker PJ (1985) Mercuric chloride-induced autoimmune glomerulopathy in BALB/c mice. (Abstract). Kidney Int 28: 702
Fraker PJ (1979) The antibody-mediated and delayed-type hypersensitivity response of mice exposed to polybrominated biphenyls. Toxicol Appl Pharmacol 53: 1–7
Fudenberg HH, Stites DP, Caldwell JL, Wells JV (eds) (1980) Basic and clinical immunology. Lange Medical Publications, Los Altos
Gainer JH (1977) Effects of heavy metals and of deficiency of zinc on mortality rates in mice infected with encephalomyocarditis virus. Am J Vet Res 38: 869–874
Gaworski CL, Sharma RP (1978) The effects of heavy metals on [3H]thymidine uptake in lymphocytes. Toxicol Appl Pharmacol 46: 305–313
Gitlin D, Vawter G, Craig JM (1964) Thymic alymphoplasia and congenital aleukocytosis. Pediatrics 33: 184–192
Glanzmann E, Rinicker P (1950) Essentielle Lymphocytophthise. Ein neues Krankheitsbild aus der Säuglingspathologie. Ann Pediat (Basel) 175: 1–32
Gleichmann H, Gleichmann E (1987) Mechanisms of autoimmunity. In: Berlin A, Dean J, Draper MH, Smith EMB, Spreafico F (eds) Immunotoxicology. Martinus Nijhoff Publishers, Dordrecht, pp 39–60
Gleichmann H, Klinkhammer C (1988) Predictive tests in immune reactions to drugs. In: Estabrook RW, Lindenlaub E, Oesch F, de Weck AL (eds) Toxicological and immunological aspects of drug metabolism and environmental chemicals. Symposia Medica Hoechst 22, Schattauer, Stuttgart, New York, pp 535–548
Gleichmann E, Pals ST, Rolink AG, Radaszkiewicz T, Gleichmann H (1984) Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunology Today 5: 324–332
Gleichmann E, Vohr H-W, Stringer C, Nuyens J, Gleichmann H (1988) Testing the sensitization of T cells to chemicals. From murine graft-versus-host reactions (GVHRs) to chemical-induced GVH-like immunological diseases. In: Kammüller ME, Bloksma N, Seinen W (eds) Autoimmunity and toxicology. Immunedysregulation induced by drugs and chemicals. Elsevier, Amsterdam, pp 363–390
Greenlee WF, Poland A (1979) Nuclear uptake of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. J Biol Chem 254: 9814–9821
Guillaume JC, Roujeau JC, Touraine R (1984) Lupus systèmique après prothèses mammaires. Ann Derm Verner 111: 703–704
Hakala M, Van Assendelft AHW, Ilonen J, Javala S, Tiilikainen A (1986) Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis. Ann Rheum Dis 45: 177–182
Hemphill FE, Kaeberle ME, Buck WB (1971) Lead suppression of mouse resistance to Salmonella typhimurium. Science 172: 1031–1032
Hindsill RD, Couch DC, Spiers RS (1980) Immunosuppression in mice induced by dioxin (TCDD) in feed. J Environ Pathol Toxicol 3:401–425
Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Conti-Tronconi B, Toyka K (1986) Myasthenia gravis: stimulation of antireceptor antibodies by autoreactive T cell lines. Neurology 36: 618–621
Hultman P, Eneström S (1987) The induction of immune complex deposits in mice by peroral and parenteral administration of mercuric chloride: strain dependent susceptibility. Clin Exp Immunol 67: 283–292
Hurtenbach U, Gleichmann H, Nagata N, Gleichmann E (1987) Immunity to d-penicillamine: genetic, cellular, and chemical requirements for induction of popliteal lymph node enlargement in the mouse. J Immunol 139: 411–416
Kammüller ME, Seinen W (1988) Structural requirements for hydantoins and 2-thiohydantoins to induce lymphoproliferative popliteal lymph node reactions in the mouse. Int J Immunopharmacol 10: 997–1010
Kammüller ME, Thomas C, De Bakker JM, Bloksma N, Seinen W (1989) The popliteal lymph node assay in mice to screen for the immune dysregulating potential of chemicals. A preliminary study. Int J Immunopharmacol 11: 293–300
Kerkvliet NI (1984) Halogenated aromatic hydrocarbons (HAH) as immunotoxicants. In: Kende M, Grainer J, Chirigos M (eds) Chemical regulation of immunity in veterinary medicine. Alan R Liss, New York, pp 369–387
Kerkvliet NI, Baecher-Steppan L (1982) Immunotoxicology studies on lead: Effects of exposure on tumor growth and cellmediated tumor immunity after syngeneic or allogeneic stimulation. Immunopharmacology 4: 213–224
Kimata H, Shinomiy K, Mikawa H (1983) Selective enhancement of human IgE production in vitro by synergy of pokeweed mitogen and mercuric chloride. Clin Exp Immunol 53: 183–191
Kimber I, Jackson JA, Stonard MD (1986a) Failure of inorganic lead exposure to impair natural killer (NK) cell and T lymphocyte function in rats. Toxicol Lett 31: 211–218
Kimber I, Stonard MD, Gidlow DA, Niewola Z (1986b) Influence of chronic low-level exposure to lead on plasma immunoglobulin concentration and cellular immune function in man. Int Arch Occup Environ Health 57: 117–125
Klinkhammer C, Popowa P, Gleichmann H (1988) Specific immunity to the diabetogen streptozotocin: cellular requirements for induction of lymphoproliferation. Diabetes 37: 74–80
Knutsen AP (1984) Immunologic effects of TCDD exposure in humans. Bull Environ Contam Toxicol 33: 673–681
Koller LD (1973) Immunosuppression induced by lead, cadmium and mercury. Am J Vet Res 34: 1457–1458
Koller LD, Kovacic S (1974) Decreased antibody formation in mice exposed to lead. Nature 250: 148–150
Koller LD, Exon JH, Roan JG (1976) Humoral antibody response in mice after single dose exposure to lead or cadmium. Proc Soc Exp Biol Med 151: 339–342
Kumagai Y, Shiokawa Y, Medsger TA Jr, Rodnan GP (1984) Clinical spectrum of connective tissue disease after cosmetic surgery. Observations of eighteen patients and a review of the Japanese literature. Arthr Rheum 27: 1–12
Lawrence DA (1981) In vivo and in vitro effects of lead on humoral and cell-mediated immunity. Infect Immun 31: 136–143
Lee TP, Chang KJ (1985) Health effects of polychlorinated biphenyls. In: Dean JH, Luster MI, Munson AE, Amos H (eds) Immunotoxicology and immunopharmacology. Raven Press, New York, pp 415–422
Lockwood CM (1987) Association of alkaline phosphatase with an autoantigen: recognition by circulating anti-neutrophil antibodies in systemic vasculitis. Lancet i: 716–719
Londei M, Botazzo GF, Feldmann M (1985) Human T cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 228: 85–89
Loose D, Silkworth JB, Pittman KA, Benitz KF and Mueller W (1978) Impaired host resistance to endotoxin and malaria in polychlorinated biphenyl-and hexachlorobenzene-treated mice. Infect Immun 20: 30–35
Luster MI, Faith RE, Kimmel CA (1978a) Depression of humoral immunity in rats following chronic developmental lead exposure. J Environ Pathol Toxicol 1: 397–402
Luster MI, Faith RE, Moore JA (1978b) Effects of polybrominated biphenyls (PBB) on immune response in rodents. Environ Health Perspect 23: 227–232
Luster MI, Boorman GA, Harris MW, Moore JA (1980) Laboratory studies on polybrominated biphenyl-induced alterations following low-level chronic or pre/postnatal exposure. Int J Immunopharmacol 2: 69–80
Malinow MR, Bardana EJ Jr, Pirofsky B, Craig S, MacLaughlin P (1982) Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science 216: 415–417
Merk H, Schneider R, Scholl P (1988) Lymphocyte Stimulation by drug-modified microsomes. In: Estabrook RW, Lindenlaub E, Oesch F, de Weck AL (eds) Toxicological and immunological aspects of drug metabolism and environmental chemicals. Symposia Medica Hoechst 22, Schattauer, Stuttgart New York, pp 211–219
Miller K, Scott MP, Foster JR (1984) Thymic involution in rats given diets containing dioctyltin dichloride. Clin Immunol Immunopathol 30: 62–70
Mirtschewa J, Nürnberger W, Hallmann B, Stiller-Winkler R, Gleichmann E (1987) Genetically determined susceptibility of mice to HgCl2-induced antinuclear antibodies (ANA) and glomerulonephritis. (Abstract). Immunobiology 175: 323–324
Nagata N, Hurtenbach U, Gleichmann E (1986) Specific sensitization of Lyt-1 +2−T cells to spleen cells modified by the drug d-penicillamine or a stereoisomer. J Immunol 136: 136–142
Nebert DW, Goujon FM, Gielen JE (1972) Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse. Nature New Biol 236: 107–110
Neilan BA, O'Neill K, Handwerger BS (1983) Effect of low-level lead exposure on antibody-dependent and natural killer cellmediated cytotoxicity. Toxicol Appl Pharmacol 69: 272–275
Okey AB, Bondy GP, Mason ME, Kahl GF, Eisen HJ, Guenthner TM, Nebert DW (1979) Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation. J Biol Chem 254: 11636–11648
Okey AB, Bondy GP, Mason ME, Nebert DW, Forster-Gibson CJ, Muncan J, Dufresne MJ (1980) Temperature-dependent cytosol-to-nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines. J Biol Chem 255: 11415–11422
Panayi GS, Huston G, Shah RR, Mitchell SC, Idle Smith JR, Waring RH (1983) Deficient sulphoxidation status and d-penicillamine toxicity. Lancet i: 414
Parker CW (1980) Drug allergy. In: Parker CW (ed) Clinical immunology. WB Saunders Co., Philadelphia, pp 2219–2260
Penn I (1977) Development of cancer as a complication of clinical transplantation. Transplant Proc 9: 1121–1127
Penn I (1985) Neoplastic consequences of immunosuppression. In: Dean JH, Luster MI, Munson AE, Amos H (eds) Immunotoxicology and immunopharmacology. Raven Press, New York, pp 79–89
Penninks AH, Seinen W (1985) On the mechanism of dialkyltininduced thymus involution. Immunopharmacology 10: 1–10
Penninks AH, Seinen W (1987) Immunotoxicity of organotin compounds. A cell biological approach to dialkyltin induced thymus atrophy. In: Berlin A, Dean JH, Draper MH, Smith EMB, Spreafico F (eds) Immunotoxicology. Martinus Nijhoff Publishers, Dordrecht, pp 258–278
Pereyo N (1980) Tartrazine-induced lupus. Shock Lett 30: 1
Perrier P, Raffoux C, Thomas Ph, Tomisier JN, Busson M, Gaucher A, Streiff F (1985) HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and d-penicillamine in patients with rheumatoid arthritis. Ann Rheum Dis 44: 621–624
Pietsch P, Allmeroth M, Gleichmann E, Vohr HW (1987) Increased synthesis of IgE, but not IgM, in strains of mice susceptible to HgCl2. (Abstract). Immunobiology 175: 324
Polak L, Barnes JM, Turk JL (1968) The genetic control of contact sensitization to inorganic metal compounds in guineapigs. Immunology 14: 707–711
Poland A, Glover E, Kende AS (1976) Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. J Biol Chem 251: 4936–4946
Ptak W, Rewicka M, Marcinkiewicz J (1984) Induction of “allogeneic effect”-like reaction by syngeneic TNP-modified lymphoid cells. Immunobiology 166: 368–381
Pujol-Borell R, Todd I, Doshi M, Botazzo GF, Sutton R, Gray D, Adolf GR, Feldmann M (1987) HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature 326: 304–306
Reggiani G (1978) Medical problems raised by TCDD contamination in Seveso, Italy. Arch Toxicol 4: 161–188
Reidenberg MM, Durant PJ, Harris RA, Debocardo G, Lahita R, Stenzel KH (1983) Lupus erythematosus-like disease due to hydrazine. Am J Med 75: 365–370
Robinson GCJ, Balazs T, Egorov IK (1986) Mercuric chloride-, gold sodium thiomalate-, and d-penicillamine-induced antinuclear antibodies in mice. Toxicol Appl Pharmacol 86: 159–169
Seinen W, Willems MI (1976) Toxicity of organotin compounds. I. Atrophy of thymus and thymus-dependent lymphoid tissue in rats fed di-n-octyltindichloride. Toxicol Appl Pharmacol 35: 63–75
Seinen W, Vos JG, Van Spanje I, Snoek M, Brands R, Hooykaas H (1977a) Toxicity of organotin compounds II. Comparative in vivo and in vitro studies with various organotin and organolead compounds in different animal species with special emphasis on lymphocyte cytotoxicity. Toxicol Appl Pharmacol 42: 197–212
Seinen W, Vos JG, Van Krieken P, Penninks A, Brands R, Hooykaas H (1977b) Toxicity of organotin compounds. III. Suppression of thymus-dependent immunity in rats by di-n-butyltin dichloride and di-n-octyltin dichloride. Toxicol Appl Pharmacol 42: 213–224
Seinen W, Vos JG, Brands R, Hooykaas H (1979) Lymphocytotoxicity and immunosuppression by organotin compounds. Suppression of GVH activity, blast transformation and E-rosette formation by di-n-butyltin dichloride and di-n-octyltin dichloride. Immunopharmacology 1: 343–355
Sell S (1987) Immunology, immunopathology, and immunity, 4th edition. Elsevier, New York, pp 310 and 320
Sharma RP, Kociba RJ, Gehring PJ (1978) Immunotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Toxicol Appl Pharmacol 45: 333 (A.266)
Shigematsu N, Ishimarus S, Saito R, Ikeda T, Matsuba K, Sugiyama K, Masuda Y (1978) Respiratory involvement in polychlorinated biphenyls poisoning. Environ Res 16: 92–100
Silkworth JB, Vecchi A (1985) Role of the Ah receptor in halogenated aromatic hydrocarbon immunotoxicity. In: Dean JH, Luster MI, Munson AE, Amos H (eds) Immunotoxicology and immunopharmacology. Raven Press, New York, pp 263–275
Stark M, Zaidi S, Hilscher B, Hilscher W, Gleichmann E (1988) Highand low-responder mouse strains with respect to silicainduced fibrosis (Abstract). Immunobiology 178: 100–101
Stejskal VDM, Olin R, Forsbeck M (1986) The lymphocyte transformation test for diagnosis of drug-induced occupational allergy. J Allergy Clin Immunol 77: 411–426
Stiller-Winkler R, Radaszkiewicz T, Gleichmann E (1988) Immunopathological signs in mice treated with mercury compounds. I. Popliteal lymph node reactions to mercury compounds: responder and non-responder mouse strains to HgCl2. Int J Immunopharmacol 10: 475–484
Taugner M, Schütz R (1966) Beitrag zur Quecksilber-Allergie. Dermatologica 133: 245–261
Thomas PJ, Hindsill RD (1978) Effect of chlorinated biphenyls on the immune responses of rhesus monkeys and mice. Toxicol Appl Pharmacol 44: 41–52
Tubbs RR, Gephardt GN, McMahon JT, Pohl MC, Vidt DG, Barenberg SA, Valenzuela R (1982) Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms. Am J Clin Pathol 77: 409–413
Victorino RMM, Maria VA (1985) Modifications of the lymphocyte transformation test in a case of drug-induced cholestatic hepatitis. Diagnostic Immunol 3: 177–181
Vogeler S, Gleichmann E (1988) Oral treatment of mice with the drug d-Penicillamine (D-Pen) haptenates their peritoneal macrophage and primes their T cells (Abstract). Immunobiology 178:71
Vos JG, Moore JA (1974) Suppression of cellular immunity in rats and mice by maternal treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Int Arch Allergy 47: 777–794
Vos JG, Van Driel-Grootenhuis L (1972) PCB-induced suppression of the humoral and cell-mediated immunity in guinea pigs. Sci Total Environ 1: 289–295
Vos JG, Moore JA, Zinkl JG (1973) Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the immune system of laboratory animals. Environ Health Perspect 5: 149–162
Vos JG, Kreeftenberg JG, Engel HWB, Minderhoud A, Van Noorlejansen LM (1978) Studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immune suppression and decreased resistance to infection: endotoxin sensitivity, serum zinc concentrations and effects of thymosin treatment. Toxicology 9: 75–86
Vos JG, De Klerk A, Krajnc EI, Kruizinga W, Van Ommen B, Rozing J (1984) Toxicity of bis(tri-n-butyltin)oxide in the rat. II. Suppression of thymus-dependent immune response and of parameters of non-specific resistance after short-term exposure. Toxicol Appl Pharmacol 75: 387–408
Webster ADB (1983) Immunodeficiency disease. In: Holborow EJ, Reeves WG (eds) Immunology in medicine, 2nd Edn. Grune and Stratton, London pp 223–241
Weening JJ, Hoedemaeker J, Bakker WW (1981) Immunoregulation and antinuclear antibodies in mercury-induced glomerulopathy in the rat. Clin Exp Immunol 45: 64–71
Weigle WO (1980) Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv Immunol 30: 159–275
Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ (1980) HLA-DR antigens and toxic reaction to sodium aurothiomalate and d-penicillamine in patients with rheumatoid arthritis. New Engl J Med 303: 300–302
Zaidi SH, Hilscher B, Hilscher W, Brassel D, Grover R (1979) Vergleichende morphometrische und autoradiographische Untersuchungen quarzinduzierter Läsionen bei nu/nuMäusen und Kontrollmäusen. In: Ergebn Unters Geb Staubund Silikosebekämpfung im Steinkohlenbergbau. Silikosebericht Nordrhein-Westfalen, Vol. 12, Verlag Glückauf, Essen, pp 187–192
Ziegler V, Haustein U-F, Mehlhorn J, Munzberger H, Rennau H (1986) Quarzinduzierte Sklerodermie. Sklerodermie-ähnliches Syndrom oder echte progressive Sklerodermie? Dermatol Monatsschr 172: 86–90
Author information
Authors and Affiliations
Additional information
This report results from a discussion sponsored and organised by the Advisory Subgroup in Toxicology (AST) of the European Science Foundations Standing Committee for the European Medical Research Councils and held at the ICI Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, UK. Those taking part were: W. N. Aldridge (AST; Toxicology Unit, Medical Research Council Laboratories, Carshalton, UK); J. Descotes (Immunotoxicology Section, Department of Pharmacology, Alexis Carrel Medical Faculty, Lyon, France); P. Druet (Groupe de Recherches sur la Pathologie Rénale et Vasculaire, INSERM U28, Hôpital Broussais, Paris, France); S. Fossum (Anatomical Institute, University of Oslo, Oslo, Norway); E. Gleichmann (Division of Immunology, Medical Institute of Environmental Hygiene, Düsseldorf, FRG); M. Haeney (Department of Immunology, Clinical Sciences Building, Hope Hospital, Salford, UK); D. Henschler (AST; Department of Toxicology and Pharmacology, University of Würzburg, FRG); B. Holmstedt (AST; Department of Toxicology, Karolinska Institute, Stockholm, Sweden); R. W. G. Johnson (Department of Surgery, Manchester Royal Infirmary, Manchester, UK); I. Kimber (ICI Central Toxicology Laboratory; Alderley Park, Macclesfield, Cheshire, UK); R. Lauwerys (AST; Industrial and Medical Toxicology Unit, University of Louvain, Brussels, Belgium); F. Lembeck (AST; Department for Experimental and Clinical Pharmacology, University of Graz, Austria); N. Lery (Laboratoire de Medecine Legale et Toxicologie Medicale, Lyon, France); G.S. Panayi (Department of Medicine, Guy's Hospital Medical School, London, UK); A. H. Penninks (Department of Veterinary Pharmacology, Pharmacy and Toxicology, University of Utrecht, Utrecht, The Netherlands); I. F. H. Purchase (AST; ICI Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, UK); B. Ryffel (Sandoz A. G., Basle, Switzerland); B. Terracini (AST; Department of Pathology and Cancer Epidemiology, University of Turin, Turin, Italy); I. Todd (Department of Immunology, Middlesex Hospital Medical School, London, UK; now Department of Immunology, University Hospital, Queen's Medical Centre, Nottingham, UK); J. G. Vos (Laboratory for Pathology, National Institute of Public Health and Environmental Hygiene, Bilthoven, The Netherlands); B. M. Vose (ICI Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, UK); J. J. Weening (Department of Pathology and Internal Medicine, University of Leiden, Leiden, The Netherlands).
Rights and permissions
About this article
Cite this article
Gleichmann, E., Kimber, I. & Purchase, I.F.H. Immunotoxicology: suppressive and stimulatory effects of drugs and environmental chemicals on the immune system. Arch Toxicol 63, 257–273 (1989). https://doi.org/10.1007/BF00278639
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00278639